| 摘要 |
<p>The invention relates to the compounds of formula I and formula II or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I or formula II; and methods for treating or preventing ventricular arrhythmias and cardiovascular diseases may be formulated for oral, buccal, rectal, topical, transdermal transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of supraventricular, ventricular arrhythmias, new-onset atrial fibrillation, Wolff- Parkinson -White syndrome.</p> |
